连续性肾臟替代疗法 (CRRT) 市场规模、份额和增长分析：按产品、按模式、按年龄组、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球连续性肾臟替代疗法（CRRT）市场规模估值为13亿美元，从2023年的14亿美元增加至2031年的26.1亿美元，在预测期内（2024-2031年）预计将以复合年增率成长8.1%。

连续性肾臟替代治疗（CRRT）市场主要受到COVID-19患者急性肾损伤（AKI）病例激增的推动，据报道CRRT的需求将达到先前人群的五倍，预计将出现显着增长。製造商和政府积极努力提高人们对 CRRT 和慢性肾臟病(CKD) 的认识，进一步推动了疫情期间使用量的增加。疫情也为当地製造商创造了有利的环境，导致对先进 CRRT 设备的需求增加。此外，儿科 CRRT 产品的进步预计将进​​一步推动市场扩张。美国在 CRRT 市场保持主导地位，受益于 AKI 的高盛行率以及拥有大量医院的强大医疗基础设施。除此之外，AKI 相关住院人数的增加和末期肾病患病率的增加是该地区市场成长的坚实基础。鑑于这些趋势，预计美国CRRT 市场在预测期内将保持稳定的复合年增长率，为医疗保健行业的相关人员带来光明的前景。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 专利分析
• 贸易分析
• 技术分析
• 价值链分析
• 客户和购买标准分析

连续性肾臟替代疗法 (CRRT) 市场：副产品

• 市场概况
• 透析液和置换液
• 消耗品
  • 血液过滤器
  • 谱系套装管
  • 其他的
• CRRT系统

连续性肾臟替代疗法 (CRRT) 市场：按方式分类

• 市场概况
• 连续性静脉血液滤过
• 连续性静脉血液滤过透析
• 连续性静脉血液血液透析机
• 缓慢连续超过滤

连续性肾臟替代疗法 (CRRT) 市场：依年龄组别

• 市场概况
• 成人
• 儿科/新生儿

连续性肾臟替代疗法 (CRRT) 市场：按最终用户分类

• 市场概况
• 医院
• 门诊治疗
• 居家医疗
• 其他的

按地区分類的连续性肾臟替代疗法 (CRRT) 市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Baxter International, Inc.（US）
• Fresenius Medical Care AG & Co. KGaA（Germany）
• Nikkiso Co., Ltd.（Japan）
• B. Braun Melsungen AG（Germany）
• Medtronic PLC（Ireland）
• Asahi Kasei Corporation（Japan）
• Toray Medical Co., Ltd.（Japan）
• Nipro Corporation（Japan）
• Infomed SA（Switzerland）
• Medica SPA（Italy）
• Medites Pharma Spol. SRO（Czech Republic）
• Medical Components, Inc.（US）
• SWS Hemodialysis Care Co., Ltd.（China）
• Ningbo Tianyi Medical Devices Co., Ltd.（China）
• Anjue Medical Equipment Co., Ltd.（China）
• Kimal（UK）
• Jiangxi Sanxin Medtech Co., Ltd.（China）
• Allmed Medical Products Co., Ltd.（China）
• Dialco Medical Inc.（US）
• Browndove Healthcare Pvt. Ltd.（India）
• Steris PLC（US）
• Kuraray Medical PLC（Japan）
• Livanova PLC（UK）
• Diaverum Deutschland GmbH（Germany）
• Sembcorp Industries（Singapore）

Global Continuous Renal Replacement Therapy Market size was valued at USD 1.30 billion in 2022 and is poised to grow from USD 1.40 billion in 2023 to USD 2.61 billion by 2031, growing at a CAGR of 8.1% in the forecast period (2024-2031).

The Continuous Renal Replacement Therapy (CRRT) market is poised for substantial growth, driven primarily by the surge in Acute Kidney Injury (AKI) cases among COVID-19 patients, with demand for CRRT reported to be five times higher than in previous populations. This increase in utilization during the pandemic has been further bolstered by proactive initiatives from both manufacturers and governments to raise awareness about CRRT and chronic kidney disease (CKD). The pandemic has also created a favorable environment for local manufacturers and led to heightened demand for advanced CRRT devices, largely due to the increasing prevalence of fluid overload and the pursuit of improved patient outcomes. Additionally, advancements in pediatric CRRT products are expected to propel market expansion further. The U.S. remains the dominant player in the CRRT market, benefiting from a high prevalence of AKI and a robust healthcare infrastructure characterized by numerous hospitals. This is compounded by the rising hospital admissions linked to AKI and the growing incidence of end-stage renal disease, providing a strong foundation for market growth in the region. As these trends unfold, the U.S. CRRT market is projected to sustain a steady compound annual growth rate (CAGR) in the forthcoming forecast period, highlighting a promising outlook for stakeholders in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the global continuous renal replacement therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global continuous renal replacement therapy Market Segmental Analysis

Global Continuous Renal Replacement Therapy Market is segmented on the product, modality, age group, end user, and region. By product, market is segmented into dialysate & replacement fluids, disposables, and CRRT Systems. By modality, market is segmented into continuous venovenous hemofiltration, continuous venovenous hemodiafiltration, continuous venovenous hemodialysis, and slow continuous ultrafiltration. By age group, market is segmented into adults, and pediatrics & neonates. By end user, market is segmented into hospitals, ambulatory care, home care, and other end users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the global continuous renal replacement therapy Market

The increasing prevalence of acute kidney injury (AKI) serves as a significant market driver for the global continuous renal replacement therapy (CRRT) market. With a rise in cases particularly among critically ill patients and individuals with pre-existing health conditions, the demand for effective renal replacement therapies is surging. AKI is frequently encountered in intensive care units, where CRRT is the preferred method due to its ability to provide continuous and controlled dialysis in unstable patients. This uptick in AKI cases not only elevates the need for CRRT devices and consumables but also enhances market growth opportunities for manufacturers and healthcare providers alike, as timely intervention is crucial for improving patient outcomes.

Restraints in the global continuous renal replacement therapy Market

The high cost of Continuous Renal Replacement Therapy (CRRT) represents a significant market restraint, particularly in regions with constrained healthcare resources and budgets. The expenses associated with CRRT treatment-including sophisticated equipment, consumables, and the need for specialized healthcare professionals-can create a financial barrier for hospitals and clinics, limiting their ability to implement these advanced therapies. Consequently, many healthcare facilities may be unable to adopt or sustain CRRT, reducing patient access to this critical treatment option. This financial strain not only hinders the adoption of CRRT but also stifles overall market growth by restricting outreach to underserved populations.

Market Trends of the global continuous renal replacement therapy Market

The global Continuous Renal Replacement Therapy (CRRT) market is witnessing significant growth driven by several interconnected trends. A surge in acute kidney injury (AKI) and chronic kidney disease (CKD) cases, particularly among the aging population and those with comorbid conditions like diabetes and hypertension, is propelling the demand for CRRT devices and consumables. Additionally, technological innovations are enhancing the efficiency and user experience of CRRT machines, with features like electronic medical record connectivity and remote monitoring improving patient outcomes. Furthermore, the trend towards home-based CRRT is gaining traction, emphasizing patient convenience and potentially lowering healthcare costs. Together, these trends highlight a robust market evolution towards advanced, patient-centric renal care solutions.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Value Chain Analysis
• Customer & Buying Criteria Analysis

Continuous Renal Replacement Therapy Market, By Product

• Market Overview
• Dialysate & Replacement Fluids
• Disposables
  • Hemofilters
  • Bloodline Sets & Tubes
  • Other Disposables
• CRRT Systems

Continuous Renal Replacement Therapy Market, By Modality

• Market Overview
• Continuous Venovenous Hemofiltration
• Continuous Venovenous Hemodiafiltration
• Continuous Venovenous Hemodialysis
• Slow Continuous Ultrafiltration

Continuous Renal Replacement Therapy Market, By Age Group

• Market Overview
• Adults
• Pediatrics & Neonates

Continuous Renal Replacement Therapy Market, By End User

• Market Overview
• Hospitals
• Ambulatory Care
• Home Care
• Other End Users

Continuous Renal Replacement Therapy Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Baxter International, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toray Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infomed SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica SPA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medites Pharma Spol. S.R.O. (Czech Republic)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medical Components, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SWS Hemodialysis Care Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ningbo Tianyi Medical Devices Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anjue Medical Equipment Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kimal (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangxi Sanxin Medtech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allmed Medical Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dialco Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Browndove Healthcare Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Steris PLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuraray Medical PLC (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Livanova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diaverum Deutschland GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sembcorp Industries (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments